These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24761886)

  • 1. Risk factors for appendiceal metastasis with epithelial ovarian cancer.
    Kokanali MK; Guzel AI; Erkilinc S; Tokmak A; Topcu HO; Gungor T
    Asian Pac J Cancer Prev; 2014; 15(6):2689-92. PubMed ID: 24761886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical role of appendectomy in surgical procedures for ovarian cancer].
    Zhang GN; Yu J; Xiao Q
    Zhonghua Fu Chan Ke Za Zhi; 1994 Nov; 29(11):662-3, 699. PubMed ID: 7712887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine appendectomy in epithelial ovarian carcinoma: is it necessary?
    Ayhan A; Gultekin M; Taskiran C; Salman MC; Celik NY; Yuce K; Usubutun A; Kucukali T
    Obstet Gynecol; 2005 Apr; 105(4):719-24. PubMed ID: 15802396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.
    Ose J; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopolou A; Benetou V; Lagiou P; Masala G; Tagliabue G; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Onland-Moret NC; Weiderpass E; Gram IT; Sánchez S; Obon-Santacana M; Sànchez-Pérez MJ; Larrañaga N; Castaño JM; Ardanaz E; Brändstedt J; Lundin E; Idahl A; Travis RC; Khaw KT; Rinaldi S; Romieu I; Merritt MA; Gunter MJ; Riboli E; Kaaks R; Fortner RT
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):951-61. PubMed ID: 25855626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for ovarian cancers with and without microsatellite instability.
    Segev Y; Pal T; Rosen B; McLaughlin JR; Sellers TA; Risch HA; Zhang S; Sun P; Narod SA; Schildkraut J
    Int J Gynecol Cancer; 2014 May; 24(4):664-9. PubMed ID: 24755492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is it necessary to perform routine appendectomy for mucinous ovarian neoplasms? A retrospective study and meta-analysis.
    Cheng A; Li M; Kanis MJ; Xu Y; Zhang Q; Cui B; Jiang J; Zhang Y; Yang X; Kong B
    Gynecol Oncol; 2017 Jan; 144(1):215-222. PubMed ID: 27889016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients.
    Okła K; Surówka J; Frąszczak K; Czerwonka A; Kaławaj K; Wawruszak A; Kotarski J; Wertel I
    Tumour Biol; 2018 Oct; 40(10):1010428318804937. PubMed ID: 30319054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthropometric factors and ovarian cancer risk in the Malmö Diet and Cancer Study.
    Brändstedt J; Nodin B; Manjer J; Jirström K
    Cancer Epidemiol; 2011 Oct; 35(5):432-7. PubMed ID: 21288792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for ovarian cancers with and without microsatellite instability.
    Segev Y; Pal T; Rosen B; McLaughlin JR; Sellers TA; Risch HA; Zhang S; Ping S; Narod SA; Schildkraut J
    Int J Gynecol Cancer; 2013 Jul; 23(6):1010-5. PubMed ID: 23748177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients.
    Li QL; Wang CJ; Qi P; Zhang YX
    Clin Transl Oncol; 2017 Oct; 19(10):1260-1267. PubMed ID: 28444641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
    Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
    Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer.
    Xu X; Deng F; Lv M; Ren B; Guo W; Chen X
    J Ovarian Res; 2016 Dec; 9(1):85. PubMed ID: 27912779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of prognostic factors on survival rates in patients with ovarian carcinoma.
    Arikan SK; Kasap B; Yetimalar H; Yildiz A; Sakarya DK; Tatar S
    Asian Pac J Cancer Prev; 2014; 15(15):6087-94. PubMed ID: 25124578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei].
    Lu YY; Guo AT; Liu AJ; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):595-601. PubMed ID: 24199925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): A series of seven cases.
    Schmoeckel E; Kirchner T; Mayr D
    Pathol Res Pract; 2018 Mar; 214(3):426-430. PubMed ID: 29487003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients.
    Chen YL; Chou CY; Chang MC; Lin HW; Huang CT; Hsieh SF; Chen CA; Cheng WF
    Endocr Relat Cancer; 2015 Oct; 22(5):703-11. PubMed ID: 26150382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
    Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
    Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
    Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L
    Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. May the platelet to lymphocyte ratio be a prognostic factor for epithelial ovarian cancer?
    Kokcu A; Kurtoglu E; Celik H; Tosun M; Malatyalıoglu E; Ozdemir AZ
    Asian Pac J Cancer Prev; 2014; 15(22):9781-4. PubMed ID: 25520104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.